Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy.

Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, Longo VD.

Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8215-20. doi: 10.1073/pnas.0708100105. Epub 2008 Mar 31.

2.

Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index.

Lee C, Safdie FM, Raffaghello L, Wei M, Madia F, Parrella E, Hwang D, Cohen P, Bianchi G, Longo VD.

Cancer Res. 2010 Feb 15;70(4):1564-72. doi: 10.1158/0008-5472.CAN-09-3228. Epub 2010 Feb 9.

3.

Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy.

Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, Martin-Montalvo A, Pistoia V, Wei M, Hwang S, Merlino A, Emionite L, de Cabo R, Longo VD.

Sci Transl Med. 2012 Mar 7;4(124):124ra27. doi: 10.1126/scitranslmed.3003293. Epub 2012 Feb 8.

4.

2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer.

Coleman MC, Asbury CR, Daniels D, Du J, Aykin-Burns N, Smith BJ, Li L, Spitz DR, Cullen JJ.

Free Radic Biol Med. 2008 Feb 1;44(3):322-31. doi: 10.1016/j.freeradbiomed.2007.08.032. Epub 2007 Oct 16.

PMID:
18215740
5.

PKCδ sensitizes neuroblastoma cells to L-buthionine-sulfoximine and etoposide inducing reactive oxygen species overproduction and DNA damage.

Marengo B, De Ciucis C, Ricciarelli R, Passalacqua M, Nitti M, Zingg JM, Marinari UM, Pronzato MA, Domenicotti C.

PLoS One. 2011 Feb 7;6(2):e14661. doi: 10.1371/journal.pone.0014661.

6.

Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.

Lun XQ, Jang JH, Tang N, Deng H, Head R, Bell JC, Stojdl DF, Nutt CL, Senger DL, Forsyth PA, McCart JA.

Clin Cancer Res. 2009 Apr 15;15(8):2777-88. doi: 10.1158/1078-0432.CCR-08-2342. Epub 2009 Apr 7.

7.

KAAD-cyclopamine augmented TRAIL-mediated apoptosis in malignant glioma cells by modulating the intrinsic and extrinsic apoptotic pathway.

Siegelin MD, Siegelin Y, Habel A, Rami A, Gaiser T.

Neurobiol Dis. 2009 May;34(2):259-66.

PMID:
19385057
8.

Therapeutic strategies by modulating oxygen stress in cancer and inflammation.

Fang J, Seki T, Maeda H.

Adv Drug Deliv Rev. 2009 Apr 28;61(4):290-302. doi: 10.1016/j.addr.2009.02.005. Epub 2009 Feb 26. Review.

PMID:
19249331
9.

The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response.

Pagnan G, Di Paolo D, Carosio R, Pastorino F, Marimpietri D, Brignole C, Pezzolo A, Loi M, Galietta LJ, Piccardi F, Cilli M, Nico B, Ribatti D, Pistoia V, Ponzoni M.

Clin Cancer Res. 2009 Feb 15;15(4):1199-209. doi: 10.1158/1078-0432.CCR-08-2477.

10.
11.

Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.

Dole MG, Jasty R, Cooper MJ, Thompson CB, Nuñez G, Castle VP.

Cancer Res. 1995 Jun 15;55(12):2576-82.

12.

Cytoprotective effect of polypeptide from Chlamys farreri on neuroblastoma (SH-SY5Y) cells following HO exposure involves scavenging ROS and inhibition JNK phosphorylation.

Ye J, Han Y, Wang C, Yu W.

J Neurochem. 2009 Oct;111(2):441-51. doi: 10.1111/j.1471-4159.2009.06328.x. Epub 2009 Aug 3.

13.

Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model.

Neuwelt EA, Pagel MA, Kraemer DF, Peterson DR, Muldoon LL.

J Pharmacol Exp Ther. 2004 May;309(2):594-9. Epub 2004 Jan 29.

14.

Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo.

Nakajima Y, Inokuchi Y, Shimazawa M, Otsubo K, Ishibashi T, Hara H.

J Pharm Pharmacol. 2008 Oct;60(10):1365-74. doi: 10.1211/jpp/60.10.0013.

PMID:
18812030
15.

Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.

Minelli A, Bellezza I, Tucci A, Rambotti MG, Conte C, Culig Z.

Prostate. 2009 Apr 1;69(5):538-47. doi: 10.1002/pros.20900.

PMID:
19107848
16.

Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues.

Chen Y, Jungsuwadee P, Vore M, Butterfield DA, St Clair DK.

Mol Interv. 2007 Jun;7(3):147-56. Review.

PMID:
17609521
17.

Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.

Lefranc F, Rynkowski M, DeWitte O, Kiss R.

Adv Tech Stand Neurosurg. 2009;34:3-35. Review.

PMID:
19368079
18.
19.
20.

The antioxidative effect of bone morphogenetic protein-7 against high glucose-induced oxidative stress in mesangial cells.

Yeh CH, Chang CK, Cheng MF, Lin HJ, Cheng JT.

Biochem Biophys Res Commun. 2009 May 1;382(2):292-7. doi: 10.1016/j.bbrc.2009.03.011. Epub 2009 Mar 9.

PMID:
19275892

Supplemental Content

Support Center